SCOPUS 정보 검색 플랫폼

International Journal of Cardiology

Volumn 181, Issue , 2015, Pages 413-414

Antiplatelet properties of oral anticoagulants

(5) Frère, Corinne a,b Laine, Marc c Paganelli, Franck c Dignat George, Françoise b Bonello, Laurent b,c

a TIMONE HOSPITAL (France)

b AIX MARSEILLE UNIVERSITY (France)

c HÔPITAL NORD (France)

Author keywords

Anticoagulants; Bleeding; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; DABIGATRAN ETEXILATE; RIVAROXABAN; ANTITHROMBOCYTIC AGENT;

ANTICOAGULATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EMBOLISM; EMBOLISM PREVENTION; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ATRIAL FIBRILLATION; BLOOD; DRUG EFFECTS; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES;

EID: 84947202096 PISSN: 01675273 EISSN: 18741754 Source Type: Journal
DOI: 10.1016/j.ijcard.2014.12.073 Document Type: Article

Times cited : (6)

References (4)

1
- 70349306707
- Dabigatran versus warfarin in patients with atrial fibrillation
- S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P.A. Reilly, E. Themeles, J. Varrone, S. Wang, M. Alings, D. Xavier, J. Zhu, R. Diaz, B.S. Lewis, H. Darius, H.C. Diener, C.D. Joyner, L. Wallentin, and RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation N. Engl. J. Med. 361 2009 1139 1151
- (2009) N. Engl. J. Med. , vol.361 , pp. 1139-1151
- Connolly, S.J.¹ Ezekowitz, M.D.² Yusuf, S.³ Eikelboom, J.⁴ Oldgren, J.⁵ Parekh, A.⁶ Pogue, J.⁷ Reilly, P.A.⁸ Themeles, E.⁹ Varrone, J.¹⁰ Wang, S.¹¹ Alings, M.¹² Xavier, D.¹³ Zhu, J.¹⁴ Diaz, R.¹⁵ Lewis, B.S.¹⁶ Darius, H.¹⁷ Diener, H.C.¹⁸ Joyner, C.D.¹⁹ Wallentin, L.²⁰ more..

2
- 80052592404
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
- M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, G. Breithardt, J.L. Halperin, G.J. Hankey, J.P. Piccini, R.C. Becker, C.C. Nessel, J.F. Paolini, S.D. Berkowitz, K.A. Fox, R.M. Califf, and ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N. Engl. J. Med. 365 2011 883 891
- (2011) N. Engl. J. Med. , vol.365 , pp. 883-891
- Patel, M.R.¹ Mahaffey, K.W.² Garg, J.³ Pan, G.⁴ Singer, D.E.⁵ Hacke, W.⁶ Breithardt, G.⁷ Halperin, J.L.⁸ Hankey, G.J.⁹ Piccini, J.P.¹⁰ Becker, R.C.¹¹ Nessel, C.C.¹² Paolini, J.F.¹³ Berkowitz, S.D.¹⁴ Fox, K.A.¹⁵ Califf, R.M.¹⁶

3
- 84875720372
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial
- W.J. Dewilde, T. Oirbans, F.W. Verheugt, J.C. Kelder, B.J. De Smet, J.P. Herrman, T. Adriaenssens, M. Vrolix, A.A. Heestermans, M.M. Vis, J.G. Tijsen, A.W. van 't Hof, J.M. ten Berg, and WOEST study investigators Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 381 2013 1107 1115
- (2013) Lancet , vol.381 , pp. 1107-1115
- Dewilde, W.J.¹ Oirbans, T.² Verheugt, F.W.³ Kelder, J.C.⁴ De Smet, B.J.⁵ Herrman, J.P.⁶ Adriaenssens, T.⁷ Vrolix, M.⁸ Heestermans, A.A.⁹ Vis, M.M.¹⁰ Tijsen, J.G.¹¹ Van 'T Hof, A.W.¹² Ten Berg, J.M.¹³

4
- 84913619061
- 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur. Heart J. 35 2014 2541 2619
- (2014) Eur. Heart J. , vol.35 , pp. 2541-2619

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.